EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Patterns of phosphorylated tau accumulation in a spectrum of acquired and developmental brain lesions associated with refractory epilepsy

Alicja Mrzyglod, Anya Mebrouk, Joanna Bartkiewicz, Hanaa El Hachami, Maritchka Ryniejska, Jane de Tisi, Roland Coras, Ingmar Blumcke iD, Fenglai Xiao iD, Anna Miserocchi, Andrew McEvoy, Matthias Koepp iD und 2 weitere

Epilepsia · 2025

DOI: 10.1111/epi.18418 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsia, 2025. Verfasst von Alicja Mrzyglod und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, London, UK. Hauptthemen laut MEDLINE: tau Proteins, Drug Resistant Epilepsy, Brain, Brain Diseases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Epilepsy Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Phosphorylated tau (pTau) has been reported in surgical resections in refractory epilepsy. It is unclear whether this is activity‐driven physiological pTau or signifies the advent of neurodegenerative cascades, relevant to memory decline. To date, primarily hippocampal sclerosis and focal cortical dysplasia (FCD) type II have been studied. We aimed to explore pTau in a range of acquired and developmental epileptogenic pathologies to assess its prevalence and identify potential drivers.

Method

A total of 104 cases were studied representing FCD IA ( n = 11), FCD IIIA ( n = 5), FCD IIIB ( n = 6), cavernoma ( n = 11), Sturge–Weber leptomeningeal angiomatosis ( n = 10), meningioangiomatosis ( n = 4), perinatal infarcts ( n = 9), Rasmussen encephalitis (RE; n = 6), gray matter heterotopia ( n = 6), old scars ( n = 10), and temporal lobe encephaloceles ( n = 7); we also included focal microinjuries following prior stereoelectroencephalography at different ages ( n = 19; four in lesion‐negative cases). pTau was evaluated with AT8 immunohistochemistry, with further multiplex panels of AT8 with other established pTau markers (AT100, AT180, PHF1, CP13), pS6, glial fibrillary acidic protein, reelin, calbindin, and Tbr1 in selected cases. Labeling in the lesion was compared with adjacent cortex and clinical factors such as epilepsy duration. Results pTau was identified in low to moderate levels in 60% overall, mainly localized to the epileptogenic lesion and more frequent in vascular malformations (74%–100%). pTau was noted in the superficial cortex across pathologies including encephaloceles, associated with superficial gliosis. In perinatal infarcts, distinct pTau patterns were noted in the superficial ulegyric cortex and heterotopic neuronal islands. Glial pTau was rare, and FCD IA, FCD IIIA/B, and microinjuries were negative. Variable regional expression of AT8 and mTOR activation markers (pS6) was noted, including in one RE case. Higher pTau expression was associated with older age at surgery and at onset of epilepsy, suggesting additional age‐related vulnerability. Significance Our findings highlight localized and distinct patterns of pTau in some epilepsy pathologies. Plausible pathomechanisms include local vascular insufficiency, neuronal dysmaturation, and aging as well as seizure activity and provide direction for future exploration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

tau ProteinsDrug Resistant EpilepsyBrainBrain DiseasesHumansFemaleMaleChildAdultAdolescentYoung AdultChild, PreschoolPhosphorylationMiddle AgedInfantReelin Protein

Stichwörter der Autor:innen

acquired scardevelopmentalfocal epilepsytau

Substanzen

tau ProteinsReelin Protein

Autor:innen und Institutionen

  • Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, London, UK.
  • Institute of Neuropathology, University Hospitals Erlangen, Erlangen, Germany.
  • School of Life Sciences, University of Westminster, London, UK.
  • Division of Neuropathology, University college London Queen Square Institute of Neurology, London, UK.

ORCID-Profile: Ingmar Blumcke, Fenglai Xiao, Matthias Koepp, Maria Thom

Förderung

  • Wellcome Trust
  • Epilepsy Society

Zitieren

APA

Mrzyglod, A., Mebrouk, A., Bartkiewicz, J., El Hachami, H., Ryniejska, M., de Tisi, J., Coras, R., Blumcke, I., Xiao, F., Miserocchi, A., McEvoy, A., Koepp, M., Liu, J., & Thom, M. (2025). Patterns of phosphorylated tau accumulation in a spectrum of acquired and developmental brain lesions associated with refractory epilepsy. Epilepsia. https://doi.org/10.1111/epi.18418

Vancouver

Mrzyglod A, Mebrouk A, Bartkiewicz J, El Hachami H, Ryniejska M, de Tisi J, et al. Patterns of phosphorylated tau accumulation in a spectrum of acquired and developmental brain lesions associated with refractory epilepsy. Epilepsia. 2025. doi:10.1111/epi.18418

BibTeX
@article{Mrzyglod2025,
  author = {Mrzyglod, Alicja and Mebrouk, Anya and Bartkiewicz, Joanna and El Hachami, Hanaa and Ryniejska, Maritchka and de Tisi, Jane and Coras, Roland and Blumcke, Ingmar and Xiao, Fenglai and Miserocchi, Anna and McEvoy, Andrew and Koepp, Matthias and Liu, Joan and Thom, Maria},
  title = {Patterns of phosphorylated tau accumulation in a spectrum of acquired and developmental brain lesions associated with refractory epilepsy},
  journal = {Epilepsia},
  year = {2025},
  doi = {10.1111/epi.18418}
}
Kostenlos starten →